CD4 and hepatocellular carcinoma: Excitingly, we found that knockdown of ENTPD2 in HCC cells reduced the number of MDSCs in the tumors as represented by CD11b+Gr+ cell population, but increased the number of CD4+ and CD8+ T-cell populations (Fig. 3e).